Lysoway Therapeutics, Inc., a biotechnology company advancing structure-guided small-molecule modulators of lysosomal ion channels to treat age-related neurodegeneration, today announced that its lead ...

Lysoway Therapeutics, Inc., a biotechnology company advancing structure-guided small-molecule modulators of lysosomal ion ...

A device smaller than a grain of dust may help unlock the kind of quantum computers people have only dreamed about. Built on ...

The Maxwell 2 sports the same 90 mm planar magnetic transducers (aka drivers), Fluxor array of magnets, and Fazor audio phase ...

About Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of ...

Ad hoc announcement pursuant to Art. 53 LR Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent EP4615820 – “Crystalline Forms of Evenamide” is ...

NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, today announces that Thomas Holm Pedersen, Chief ...

Ionis Pharmaceuticals, Inc. today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference at 8:15 a.m. PT on ...

Cognyte Software Ltd. ("Cognyte"), a global leader in software-driven technology for investigative analytics, today announced that Elad Sharon, Cognyte's Chief Executive Officer, and David Abadi, ...

Xenon ( ($XENE) ) has provided an announcement. Xenon Pharmaceuticals Inc. announced that President and CEO Ian Mortimer will present a company ...

This is an important study on the sensory roles of Cerebrospinal fluid-contacting neurons (CBF-cn) in mammals. The authors identify PKD2L1 as the predominant pH-sensing channel CBF-cn and show how the ...